Exagen Inc. XGN Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s preferred stock, par or stated value per share?
- Exagen Inc. (XGN) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Exagen Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Exagen Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Exagen Inc.'s preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Exagen Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.